Status:

UNKNOWN

Study of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) Patients

Lead Sponsor:

The First Affiliated Hospital of Soochow University

Collaborating Sponsors:

Changshu Frist People's Hospital

The Second People's Hospital of Huai'an

Conditions:

Multiple Myeloma

Eligibility:

All Genders

18-75 years

Phase:

PHASE3

Brief Summary

The purpose of this study is to evaluate the safety and efficacy of BiRd regimen combined with BCMA CAR T cell therapy in newly diagnosed multiple myeloma patients

Detailed Description

This is a phase 3, single arm, multi-center study. The patients will receive BiRd regimen (clarithromycin,lenalidomide, dexamethasone) combined with infusion of autologous BCMA-directed CAR T-cells in...

Eligibility Criteria

Inclusion

  • Newly diagnosed MM according to the criteria by International Myeloma Working Group (IMWG)
  • Age 18-75
  • Eastern Cooperative Oncology Group (ECOG) score 0-2
  • BCMA positive as detected with flowcytometry or ELISA.
  • Patients with left ventricular ejection fraction ≥ 0.5 by echocardiography or grade I/II cardiovascular dysfunction according to the New York Heart Association Classification.
  • Patients with aspartate aminotransferase or glutamic-pyruvic transaminase \> 3x upper limit of normal or bilirubin \> 2.0 mg/dL

Exclusion

  • Patients are pregnant or lactating.
  • Nonsecretory MM.
  • History of previous treatment of MM.
  • Patients with uncontrolled active infection.
  • Patients with active hepatitis B or hepatitis C infection.
  • Patients with HIV infection.
  • Patients with atrial or venous thrombosis or embolism.
  • Patients with myo-infarction or severe arrythmia in the recent 6 months.
  • Other comorbidities that investigators considered not suitable for this study.

Key Trial Info

Start Date :

October 19 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 31 2025

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT04287660

Start Date

October 19 2017

End Date

January 31 2025

Last Update

October 25 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The First Affiliated Hospital of Soochow University

Suzhou, Jiangsu, China, 215006